Vitamin D status in Israeli subjects before the initiation and after the cessation of Vitamin D supplements

Calcified Tissue International

Volumn 89, Issue 5, 2011, Pages 419-425

  Saliba, Walid ^a   Barnett, Ofra ^a   Rennert, Hedy S ^a   Lavi, Idit ^a   Rennert, Gad ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

Author keywords

25OHD; Cholecalciferol; Treatment cessation; Vitamin D

Indexed keywords

CALCIFEDIOL; COLECALCIFEROL; VITAMIN D;

ADULT; AGE; AGED; ARAB; ARTICLE; BODY MASS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ETHNIC GROUP; ETHNICITY; FEMALE; GENDER; HUMAN; ISRAELI; JEW; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEASONAL VARIATION; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGED; BONE DENSITY CONSERVATION AGENTS; CHOLECALCIFEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 82755197635     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9536-7     Document Type: Article

References (25)

1. Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF (2006) Vitamin D and cancer. Anticancer Res 26:2515-2524 (Pubitemid 44155530)
2. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R (2010) Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: The Tromsø study. Eur J Endocrinol 162:935-942
3. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353-373 (Pubitemid 43334631)
4. National Academy of Science, Institute of Medicine (2010) Dietary references intake for calcium and vitamin D. http://www. nap.edu/catalog.php? record-id=13050. Accessed 1 Apr 2011
5. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53-58
6. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266-281
7. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales- Torres J (2009) IOF Committee of Scientific Advisors (CSA) Nutrition Working Group (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20:1807-1820
8. Saliba W, Rennert HS, Kershenbaum A, Rennert G (2011) Serum 25(OH)D concentrations in sunny Israel. Osteoporos Int (in press)
9. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF (1998) Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 8:222-230 (Pubitemid 28427071)
10. Aloia JF, Patel M, Dimaano R, Li-Ng M, Talwar SA, Mikhail M, Pollack S, Yeh JK (2008) Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 87:1952-1958 (Pubitemid 351872664)
11. Talwar SA, Aloia JF, Pollack S, Yeh JK (2007) Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr 86:1657-1662 (Pubitemid 350232180)
12. Kyriakidou-Himonas M, Aloia JF, Yeh JK (1999) Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab 84:3988-3990 (Pubitemid 30644184)
13. Vieth R, Chan PC, MacFarlane GD (2001) Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 73:288-294 (Pubitemid 32109858)
14. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204-210 (Pubitemid 36015393)
15. Castelo-Branco C, Cortés X, Ferrer M, UNICAD Study Investigators (2010) Treatment persistence and compliance with a combination of calcium and vitamin D. Climacteric 13:578-584
16. McKenna MJ, Freaney R, Meade A, Muldowney FP (1985) Prevention of hypovitaminosis D in the elderly. Calcif Tissue Int 37:112-116 (Pubitemid 15064725)
17. Byrne PM, Freaney R, McKenna MJ (1995) Vitamin D supplementation in the elderly: review of safety and effectiveness of different regimes. Calcif Tissue Int 56:518-520
18. Pearce SH, Cheetham TD (2010) Diagnosis and management of vitamin D deficiency. BMJ 340:142-147
19. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815-1822
20. Hyppönen E, Power C (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85:860-868 (Pubitemid 46393520)
21. Chan SP, Scott BB, Sen SS (2010) An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: physician and patient attitudes and beliefs. BMC Musculoskelet Disord 11:248
22. Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Treatment of Osteoporosis in Clinical Practice (TOP) Study Group (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914-921 (Pubitemid 43781506)
23. Brunner R, Dunbar-Jacob J, Leboff MS, Granek I, Bowen D, Snetselaar LG, Shumaker SA, Ockene J, Rosal M, Wactawski- Wende J, Cauley J, Cochrane B, Tinker L, Jackson R, Wang CY, Wu L (2009) Predictors of adherence in the Women's Health Initiative Calcium and Vitamin D Trial. Behav Med 34:145-155
24. Lee P, Greenfield JR, Seibel MJ, Eisman JA, Center JR (2009) Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med 122:1056-1060
25. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911-1930